Imagion Biosystems has announced “Chairman’s Address to Shareholders at Annual General Meeting”.
View the Chairman’s Address.
Chairman's Address to Shareholders at Annual General Meeting
Highlights: Announced preliminary performance of MagSense® HER2 Imaging Agent in phase 1 study after study closure (post quarter end) Entered a strategic partnership with Prestige
Transforming medical imaging for early disease detection
We’re on a mission to make cancer more detectable.